Swiss should intensify cooperation with Covax, say experts
Some of the poorest countries in the world currently have as little as 0.1 Covid vaccine doses per 100 inhabitants, the SonntagsZeitung reported.
Keystone / Antonio Dasiparu
To effectively fight the global pandemic, rich countries like Switzerland should donate their surplus Covid-19 vaccines to poorer countries immediately, says Thomas Cueni, president of the International Federation of Pharmaceutical Manufacturers and Associations.
This content was published on
2 minutes
swissinfo.ch/gw
العربية
ar
خبراء: يجب على سويسرا تكثيف التعاون مع مبادرة “كوفاكس” العالمية
“We won’t get out of the pandemic unless everyone is vaccinated,” Cueni told the SonntagsZeitung newspaper, adding that a problem with distribution – and not production – of the vaccine was preventing poorer countries from inoculating their populations.
Pharmaceutical companies from Europe to Asia are capable of manufacturing 11 billion doses of the Covid vaccine by the end of 2021, said the Swiss national, who sits on the coordination committee of the Covax Initiative aimed at guaranteeing universal access to the vaccine.
“This would be enough to vaccinate the world’s adult population, if the vaccines were distributed fairly.”
While Switzerland has purchased enough vaccines for its entire population and approved vaccination for adolescents, Haiti has less than 0.1 vaccine doses per 100 inhabitants, the newspaper reported. Many countries in Africa, Asia and the Middle East suffer from a similar lack of vaccines.
“It’s shocking that certain rich countries have started vaccinating 12- to 16-year-olds, while many poor countries don’t even have vaccines for vulnerable populations,” said Cueni.
Unused vaccines set to expire
Although the Swiss government pledged on June 30 to donate four million doses of the Astra Zeneca vaccine to Covax, to date none have been delivered, Cueni pointed out. A spokesperson for the Federal Office of Public Health told the SonntagsZeitung work was ongoing to implement the donation.
“Switzerland should intensify its cooperation with Covax and get even more involved,” said epidemiologist Marcel Tanner, president of the Swiss Academies of Arts and Sciences.
Greater distributive justice was all the more urgent as millions of vaccine doses sitting unused in rich countries will soon expire, said Tanner, who added that these should be donated to countries in need without delay.
Popular Stories
More
Aging society
No house generation: the impossibility of buying property in Switzerland
Swatch shareholders reject board bid by Steven Wood
This content was published on
At the Swiss watchmaker’s Annual General Meeting on Wednesday, 79.2% of votes cast opposed his election to the supervisory board.
WHO members agree to 20% rise in mandatory contributions
This content was published on
If the resolution is backed in the plenary session, the organisation’s budget for 2026-2027 will rise to CHF4.2 billion ($5.1 billion).
Japanese inflatable concert hall heads to Switzerland for the first time
This content was published on
The Ark Nova has been assembled four times to date – each time in a Japanese city. But this September, it’s heading to the Lucerne Festival.
Swiss government pledges CHF11 million to UNRWA amid Gaza crisis
This content was published on
Switzerland will contribute CHF20 million to meet urgent humanitarian needs in the occupied Palestinian territory and to support UNRWA operations.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
In the vaccine race, can COVAX help poorer countries catch up?
This content was published on
COVAX expects to start rolling out Covid-19 vaccines to poorer countries at the end of February. Can it really help them catch up?
Swiss living in Covid-19 hotspots unable to get Covid vaccine
This content was published on
The head of the Organisation of the Swiss Abroad has called on the government to ensure that expatriate Swiss citizens get access to Covid vaccines.
Switzerland clears Pfizer/BioNTech vaccine for 12 to 15-year-olds
This content was published on
The Swiss health regulator Swissmedic has approved the use of the Pfizer/BioNTech vaccine for children aged as young as 12.
Latest COVAX funding drive gathers over CHF2 billion
This content was published on
At an online summit of the GAVI allianceExternal link on Wednesday, attended by Swiss President Guy Parmelin, a total of CHF2.16 billion and 54 million additional vaccine shots were pledged by dozens of countries to the COVAX vaccine-sharing pool. The COVAX mechanism, which has distributed 77 million doses to 127 countries, aims to accelerate access…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.